DP-DCT 1.0：A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform
Clinical trial NCT07595289 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07595289
- Sponsor
- The Third Xiangya Hospital of Central South University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2026-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.